Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis

Clinical trial NCT07281924 · RECRUITING

Trial details

NCT number: NCT07281924
Sponsor: University of Wisconsin, Madison
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Melanoma Liver Metastases

Start date: 2026-08-01
Primary completion: 2030-12-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.